CC
SZYM

Chase Coleman’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Chase Coleman’s Portfolio SZYM Stock Details SZYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-500,000
Closed -$1.29M – 64
2014
Q4 		$1.29M Buy
+500,000
New +$2.19M 0.02% 60

Other funds holding SZYM

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
PC
Passport Capital San Francisco, California $394M AUM 50.67% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Chase Coleman's SZYM Position: Q1 2015 in Review

Chase Coleman sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q1 2015, closing a stake of 500,000 shares — an estimated $1.29M sold.

Chase Coleman first reported a position in SZYM in Q4 2014 and held it in 1 quarter. The position peaked at $1.29M in Q4 2014. 102 funds tracked by Wall St. Rank hold SZYM as of Q1 2015.

  • Chase Coleman reported no remaining SOLAZYME INC COM STK (DE) position as of Q1 2015 after selling out during the quarter.
  • Chase Coleman sold 500,000 SOLAZYME INC COM STK (DE) shares in Q1 2015, an estimated $1.29M.
  • Chase Coleman first reported a position in SOLAZYME INC COM STK (DE) in Q4 2014 and held it in 1 quarter.
  • Chase Coleman's SOLAZYME INC COM STK (DE) position peaked at $1.29M in Q4 2014.
  • 102 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q1 2015.

Based on Tiger Global Management's 13F filing for Q1 2015, filed 15 May 2015.